RIVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR
Identification of Riva-Efavirenz/Emtricitabine/Tenofovir
| No description |
Google image searchProduct monograph
Active ingredients
efavirenz, 600 MG
emtricitabine, 200 MG
tenofovir disoproxil fumarate, 300 MG
DIN: 02518716
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: LABORATOIRE RIVA INC.
Date: 25-AUG-2021
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AR — Antivirals for treatment of HIV infections, combinations (ATC, ATC/DDD)
- J05AR06 — EMTRICITABINE, TENOFOVIR DISOPROXIL AND EFAVIRENZ (ATC/DDD)
Reference brand drug: Atripla
Pharmaceutical standard: MFR
